New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dermata Therapeutics, Inc.
DRMA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Biotechnology

Next Earning date - 14 Nov 2024

2M

Biotechnology

Next Earning date - 14 Nov 2024

1.35USD
Shape0.01 ( 0.75%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

91%

Quote Panel

Shape
Updated October 12, 2024
1W 3.01 % 1M -13.29 % 3M -37.44 % 1Y -87.82 %

Key Metrics

Shape
  • Market Cap

    2.04M


  • Shares Outstanding

    1.51M


  • Share in Float

    1.48M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1.35


  • Average Volume

    2.56M


  • Beta

    0.778


  • Range

    1.29-14.625


  • Industry

    Biotechnology


  • Website

    https://www.dermatarx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.28x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-18.7

EPS

How DRMA compares to sector?

P/E Ratio

Relative Strength

Shape

DRMA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$3.87

Shape7%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2022-02-07

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.20
vs -13.76

Q4.22

arrow
arrow

N/A

-1.92
vs -4.16

Q1.23

arrow
arrow

N/A

-2.27
vs -5.28

Q2.23

arrow
arrow

N/A

-0.63
vs -3.84

Q3.23

arrow
arrow

N/A

-0.54
vs -3.20

Q4.23

arrow
arrow

N/A

-3.15
vs -1.92

Q1.24

arrow
arrow

N/A

-7.05
vs -2.27

Q2.24

arrow
arrow

N/A

-4.18
vs -0.63

Q3.24

arrow
arrow

N/A

-2.64
vs -0.54

Q4.24

arrow
arrow

N/A

-1.36
vs -3.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-32%

-0.32
vs -0.28

Q4.22

arrow
arrow

-26%

-0.26
vs -0.32

Q1.23

arrow
arrow

-27%

-0.27
vs -0.26

Q2.23

arrow
arrow

-21%

-0.21
vs -0.27

Q3.23

arrow
arrow

-27%

-0.27
vs -0.21

Q4.23

arrow
arrow

-34%

-0.34
vs -0.27

Q1.24

arrow
arrow

-82%

-0.82
vs -0.34

Q2.24

arrow
arrow

-85%

-0.85
vs -0.82

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

8

8
vs NA

NA

Q4.21

arrow
arrow

10

10
vs 8

25%

Q1.22

arrow
arrow

7

7
vs 10

-30%

Q2.22

arrow
arrow

10

10
vs 7

43%

Q3.22

arrow
arrow

9

9
vs 10

-10%

Q4.22

arrow
arrow

11

11
vs 9

22%

Earnings Growth

Latest News